Dear Colleagues,
The editorial team would like to congratulate the winners of the Cancers 2019 Best Paper Awards, who were chosen by a Selection Committee chaired by the Editor-in-Chief, Prof. Dr. Samuel C. Mok. Following a review process by the Evaluation Committee, four winners were selected. The recipients of the “Cancers 2019 Best Paper Awards” are as follows:
Article:
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid (doi: 10.3390/cancers11050674)
By: Lynsey M. Whilding, Leena Halim, Benjamin Draper, Ana C. Parente-Pereira, Tomasz Zabinski, David Marc Davies and John Maher
Cancers 2019, 11(5), 674.
Blockade of Lactate Dehydrogenase-A (LDH-A) Improves Efficacy of Anti-Programmed Cell Death-1 (PD-1) Therapy in Melanoma (doi: 10.3390/cancers11040450)
By: Saeed Daneshmandi, Barbara Wegiel and Pankaj Seth
Cancers 2019, 11(4), 450.
Review:
Gut Microbiota and Cancer: From Pathogenesis to Therapy (doi: 10.3390/cancers11010038)
By: Silvia Vivarelli, Rossella Salemi, Saverio Candido, Luca Falzone, Maria Santagati, Stefania Stefani, Francesco Torino, Giuseppe Luigi Banna, Giuseppe Tonini and Massimo Libra
Cancers 2019, 11(1), 38.
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging—A Literature Review (doi: 10.3390/cancers11071033)
By: Gabrielle Planes-Laine, Philippe Rochigneux, François Bertucci, Anne-Sophie Chrétien, Patrice Viens, Renaud Sabatier and Anthony Gonçalves
Cancers 2019, 11(7), 1033.
Each winner (corresponding author) will receive 500 CHF and a chance to publish a paper free of charge in Cancers in 2021 after the normal peer-review procedure.
Please join us in congratulating the winners of Cancers 2019 Best Paper Awards. We would also like to take this opportunity to thank all of our authors for their continued support of Cancers.
Kind regards,
Cancers Editorial Office
Cancers 2019 Best Paper Award
Eligibility and Requirements
– All papers published in Cancers will be eligible (Both regular and Special Issue submissions).
Winner
Open AccessArticle
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab
by
Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi and Silvia Morbelli
Winner
Open AccessEditor’s ChoiceArticle
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
by
Timothy Crook, Robert Leonard, Kefah Mokbel, Alastair Thompson, Michael Michell, Raymond Page, Ashok Vaid, Ravi Mehrotra, Anantbhushan Ranade, Sewanti Limaye, Darshana Patil, Dadasaheb Akolkar, Vineet Datta, Pradip Fulmali, Sachin Apurwa, Stefan Schuster, Ajay Srinivasan and Rajan Datar
Open AccessEditor’s ChoiceArticle
T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity
by
Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel, Maja Bürdek, Susanne Wilde and Daniel Sommermeyer
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center
Prof. Donat Kögel
Klinikum der Goethe-Universität Frankfurt
Dr. Nicola Amodio
Università Magna Graecia di Catanzaro
Winner
John Maher
King’s College London, School of Cancer and Pharmaceutical Studies, Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK
https://www.mdpi.com/2072-6694/11/5/674
Barbara Wegiel
Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
https://www.mdpi.com/2072-6694/11/4/450
Massimo Libra
Department of Biomedical and Biotechnological Sciences, Oncologic, Clinic and General Pathology Section, University of Catania, 95123 Catania, Italy
https://www.mdpi.com/2072-6694/11/1/38
Anthony Gonçalves
Department of Medical Oncology, Aix-Marseille University, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, 13009 Marseille, France
https://www.mdpi.com/2072-6694/11/7/1033
Award Committee
Dr. Samuel Mok
Chairman
UT MD Anderson Cancer Center